Immunocore Holdings Plc (IMCR)
30.31
+0.16
(+0.53%)
USD |
NASDAQ |
Apr 01, 16:00
30.24
-0.07
(-0.23%)
After-Hours: 20:00
Immunocore Holdings Total Liabilities (Quarterly) : 686.24M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 138.34M |
| Haleon Plc | -- |
| Silence Therapeutics Plc | 69.14M |
| Adaptimmune Therapeutics Plc | 201.59M |
| Biodexa Pharmaceuticals Plc | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.067B |
| Shareholders Equity (Quarterly) | 381.03M |
| Debt to Equity Ratio | 1.146 |
| Current Ratio | 4.040 |
| Net Debt Paydown Yield | 0.50% |